Why Pharma Companies Take on Fragile X, Explained

Research aimed at finding Fragile X syndrome treatments is exploding. Why are so many companies investing? FRAXA CSO Dr. Michael Tranfaglia explains many reasons Fragile X is a hot topic.

Read More »

How FRAXA Prioritizes Research, Explained

Dr. Mike Tranfaglia explains how FRAXA prioritizes research. "It’s not either-or. It’s not we have a definitive treatment or we have a new drug treatment or we have a repurposing treatment.

Read More »

What FRAXA Is Excited about in the Upcoming Fragile X Research Grants, Explained

Many new clinical trials are starting, with existing and investigational drugs and other treatment strategies that have been tested in the Fragile X mouse models moving to patients in clinical trials.

Read More »

Gordon Research Conference for Fragile X and Autism-Related Disorders, Explained

The Fragile X and Autism-Related Disorders Gordon Research Conference is a biannual event, an international forum for the presentation and discussion of frontier research in these conditions.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (37)